{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:43:20Z","timestamp":1792421000309,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hepatitis E virus (HEV) is the most common cause of acute hepatitis. While symptoms are generally mild and resolve within weeks, some populations (e.g., pregnant women, immunocompromised adults) are at high-risk of severe HEV-related morbidity and mortality. There has not been a recent comprehensive review of contemporary HEV outbreaks, which limits the validity of current disease burden estimates. Therefore, we aimed to characterize global HEV outbreaks and describe data gaps to inform HEV outbreak prevention and response initiatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review of peer-reviewed (PubMed, Embase) and gray literature (ProMED) to identify reports of outbreaks published between 2011 and 2022. We included (1) reports with \u2265\u20095 cases of HEV, and\/or (2) reports with 1.5 times the baseline incidence of HEV in a specific population, and (3) all reports with suspected (e.g., clinical case definition) or confirmed (e.g., ELISA or PCR test) cases if they met criterium 1 and\/or 2. We describe key outbreak epidemiological, prevention and response characteristics and major data gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 907 records from PubMed, 468 from Embase, and 247 from ProMED. We screened 1,362 potentially relevant records after deduplication. Seventy-one reports were synthesized, representing 44 HEV outbreaks in 19 countries. The populations at risk, case fatalities, and outbreak durations were not reported in 66% of outbreak reports. No reports described using HEV vaccines. Reported intervention efforts included improving sanitation and hygiene, contact tracing\/case surveillance, chlorinating boreholes, and advising residents to boil water. Commonly missing data elements included specific case definitions used, testing strategy and methods, seroprevalence, impacts of interventions, and outbreak response costs. Approximately 20% of HEV outbreaks we found were not published in the peer-reviewed literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HEV represents a significant public health problem. Unfortunately, extensive data shortages and a lack of standardized reporting make it difficult to estimate the HEV disease burden accurately and to implement effective prevention and response activities. Our study has identified major gaps to guide future studies and outbreak reporting systems. Our results support the development of standardized reporting procedures\/platforms for HEV outbreaks to ensure accurate and timely data distribution, including active and passive coordinated surveillance systems, particularly among high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-023-15792-8","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T09:02:43Z","timestamp":1686560563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives"],"prefix":"10.1186","volume":"23","author":[{"given":"Fatima H.","family":"Al-Shimari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camerin A.","family":"Rencken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten S.","family":"Vannice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barclay T.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"15792_CR1","unstructured":"World Health Organization, Hepatitis E, Accessed. February 22, 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e."},{"issue":"31","key":"15792_CR2","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","volume":"22","author":"MS Khuroo","year":"2016","unstructured":"Khuroo MS, Khuroo MS, Khuroo NS, Hepatitis E. Discovery, global impact, control and cure. World J Gastroenterol. 2016;22(31):7030\u201345. https:\/\/doi.org\/10.3748\/wjg.v22.i31.7030.","journal-title":"World J Gastroenterol"},{"issue":"37","key":"15792_CR3","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3748\/wjg.v26.i37.5543","volume":"26","author":"AT Aslan","year":"2020","unstructured":"Aslan AT, Balaban HY. Hepatitis E virus: epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol. 2020;26(37):5543\u201360. https:\/\/doi.org\/10.3748\/wjg.v26.i37.5543.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"15792_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/v11050456","volume":"11","author":"PP Primadharsini","year":"2019","unstructured":"Primadharsini PP, Nagashima S, Okamoto H. Genetic variability and evolution of Hepatitis E Virus. Viruses. 2019;11(5):456. https:\/\/doi.org\/10.3390\/v11050456.","journal-title":"Viruses"},{"key":"15792_CR5","doi-asserted-by":"publisher","first-page":"100186","DOI":"10.1016\/j.onehlt.2020.100186","volume":"11","author":"H Bagulo","year":"2021","unstructured":"Bagulo H, Majekodunmi AO, Welburn SC. Hepatitis E in sub Saharan Africa - A significant emerging disease. One Health Amst Neth. 2021;11:100186. https:\/\/doi.org\/10.1016\/j.onehlt.2020.100186.","journal-title":"One Health Amst Neth"},{"issue":"9835","key":"15792_CR6","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"N Kamar","year":"2012","unstructured":"Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. The Lancet. 2012;379(9835):2477\u201388. https:\/\/doi.org\/10.1016\/S0140-6736(11)61849-7.","journal-title":"The Lancet"},{"key":"15792_CR7","unstructured":"Hepatitis E-. FAQs, Resources, and Testing Requests | CDC. Published March 30, 2021. Accessed February 26, 2022. https:\/\/www.cdc.gov\/hepatitis\/hev\/index.htm."},{"issue":"1","key":"15792_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12884-020-03116-2","volume":"20","author":"JJ Bigna","year":"2020","unstructured":"Bigna JJ, Modiyinji AF, Nansseu JR, et al. Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020;20(1):426. https:\/\/doi.org\/10.1186\/s12884-020-03116-2.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"15792_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0377-1237(06)80100-0","volume":"62","author":"P Singh","year":"2006","unstructured":"Singh P, Handa SK, Banerjee A. Epidemiological investigation of an outbreak of viral Hepatitis. Med J Armed Forces India. 2006;62(4):332\u20134. https:\/\/doi.org\/10.1016\/S0377-1237(06)80100-0.","journal-title":"Med J Armed Forces India"},{"issue":"12","key":"15792_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1086\/504322","volume":"42","author":"D Boccia","year":"2006","unstructured":"Boccia D, Guthmann JP, Klovstad H, et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;42(12):1679\u201384. https:\/\/doi.org\/10.1086\/504322.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"Suppl","key":"15792_CR11","first-page":"145","volume":"45","author":"R Viswanathan","year":"1957","unstructured":"Viswanathan R. A review of the literature on the epidemiology of infectious hepatitis. Indian J Med Res. 1957;45(Suppl):145\u201355.","journal-title":"Indian J Med Res"},{"issue":"1","key":"15792_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000149370","volume":"20","author":"MS Balayan","year":"1983","unstructured":"Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23\u201331. https:\/\/doi.org\/10.1159\/000149370.","journal-title":"Intervirology"},{"issue":"4","key":"15792_CR13","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/hep.25505","volume":"55","author":"DB Rein","year":"2012","unstructured":"Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988\u201397. https:\/\/doi.org\/10.1002\/hep.25505.","journal-title":"Hepatology"},{"issue":"9744","key":"15792_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"FC Zhu","year":"2010","unstructured":"Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet Lond Engl. 2010;376(9744):895\u2013902. https:\/\/doi.org\/10.1016\/S0140-6736(10)61030-6.","journal-title":"Lancet Lond Engl"},{"key":"15792_CR15","doi-asserted-by":"publisher","unstructured":"Andrews RE, Fenton MJ, Burch M. Paediatric heart failure from heart muscle disease in the UK and Ireland: 51 Year Follow Up. Cardiol Young. 2014;24((Andrews R.E.; Fenton M.J.; Burch M.) Great Ormond Street Hospital for Children, London, United Kingdom):S15. https:\/\/doi.org\/10.1017\/S1047951114000559.","DOI":"10.1017\/S1047951114000559"},{"issue":"37","key":"15792_CR16","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1016\/j.vaccine.2017.05.072","volume":"35","author":"YF Cao","year":"2017","unstructured":"Cao YF, Tao H, Hu YM, et al. A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine. Vaccine. 2017;35(37):5073\u201380. https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.072.","journal-title":"Vaccine"},{"issue":"10","key":"15792_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/pathogens9100856","volume":"9","author":"SR Pallerla","year":"2020","unstructured":"Pallerla SR, Harms D, Johne R, et al. Hepatitis E Virus infection: circulation, Molecular Epidemiology, and impact on Global Health. Pathogens. 2020;9(10):856. https:\/\/doi.org\/10.3390\/pathogens9100856.","journal-title":"Pathogens"},{"key":"15792_CR18","unstructured":"WHO | Rapid reviews to strengthen health policy and systems: a practical guide. WHO. Accessed March 3., 2022. http:\/\/www.who.int\/alliance-hpsr\/resources\/publications\/rapid-review-guide\/en\/."},{"key":"15792_CR19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ Published online March. 2021;29:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ Published online March"},{"issue":"2","key":"15792_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1547-5069.2003.00177.x","volume":"35","author":"VS Conn","year":"2003","unstructured":"Conn VS, Isaramalai S, arun, Rath S, Jantarakupt P, Wadhawan R, Dash Y. Beyond MEDLINE for literature searches. J Nurs Scholarsh Off Publ Sigma Theta Tau Int Honor Soc Nurs. 2003;35(2):177\u201382. https:\/\/doi.org\/10.1111\/j.1547-5069.2003.00177.x.","journal-title":"J Nurs Scholarsh Off Publ Sigma Theta Tau Int Honor Soc Nurs"},{"issue":"1","key":"15792_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.13237","volume":"37","author":"MS Hakim","year":"2017","unstructured":"Hakim MS, Wang W, Bramer WM, et al. The global burden of hepatitis E outbreaks: a systematic review. Liver Int. 2017;37(1):19\u201331. https:\/\/doi.org\/10.1111\/liv.13237.","journal-title":"Liver Int"},{"key":"15792_CR22","unstructured":"Search ProMED Posts - ProMED-mail. Accessed March 3., 2022. https:\/\/promedmail.org\/promed-posts\/."},{"issue":"1","key":"15792_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12879-020-04961-4","volume":"20","author":"V Tricou","year":"2020","unstructured":"Tricou V, Bouscaillou J, Laghoe-Nguembe GL, et al. Hepatitis E virus outbreak associated with rainfall in the central African Republic in 2008\u20132009. BMC Infect Dis. 2020;20(1):260. https:\/\/doi.org\/10.1186\/s12879-020-04961-4.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"15792_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/trstmh\/tru123","volume":"108","author":"MJ Cummings","year":"2014","unstructured":"Cummings MJ, Wamala JF, Komakech I, et al. Hepatitis E in Karamoja, Uganda, 2009\u20132012: epidemiology and challenges to control in a setting of semi-nomadic pastoralism. Trans R Soc Trop Med Hyg. 2014;108(10):648\u201355. https:\/\/doi.org\/10.1093\/trstmh\/tru123.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"15792_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/v13061159","volume":"13","author":"AR Garbuglia","year":"2021","unstructured":"Garbuglia AR, Bruni R, Villano U, et al. Hepatitis E outbreak in the Central Part of Italy sustained by multiple HEV genotype 3 strains, June\u2013December 2019. Viruses. 2021;13(6):1159. https:\/\/doi.org\/10.3390\/v13061159.","journal-title":"Viruses"},{"key":"15792_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijid.2019.07.006","volume":"86","author":"W Yin","year":"2019","unstructured":"Yin W, Han Y, Xin H, et al. Hepatitis E outbreak in a mechanical factory in Qingdao City, China. Int J Infect Dis. 2019;86:191\u20136. https:\/\/doi.org\/10.1016\/j.ijid.2019.07.006.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"15792_CR27","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1002\/jmv.26277","volume":"93","author":"AF Modiyinji","year":"2021","unstructured":"Modiyinji AF, Rivero-Juarez A, Lopez-Lopez P, et al. First molecular characterization of the hepatitis E virus in humans in Cameroon: confirmation of the HEV outbreak in Touboro, North-Cameroon. J Med Virol. 2021;93(6):4018\u201322. https:\/\/doi.org\/10.1002\/jmv.26277.","journal-title":"J Med Virol"},{"issue":"1","key":"15792_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/ijmm.IJMM_19_433","volume":"38","author":"B Malhotra","year":"2020","unstructured":"Malhotra B, Deba F, Sharma P, et al. Hepatitis E outbreak in Jaipur due to genotype IA. Indian J Med Microbiol. 2020;38(1):46\u201351. https:\/\/doi.org\/10.4103\/ijmm.IJMM_19_433.","journal-title":"Indian J Med Microbiol"},{"key":"15792_CR29","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Promed Post. ProMED-mail. Accessed March 8., 2022. https:\/\/promedmail.org\/promed-post\/."},{"key":"15792_CR30","unstructured":"Notes from the Field: Nationwide Hepatitis E Outbreak Concentrated in Informal Settlements \u2014 Namibia, 2017\u20132020 | MMWR. Accessed March 6., 2022. https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6912a6.htm?s_cid=mm6912a6_w."},{"issue":"29","key":"15792_CR31","first-page":"581","volume":"62","author":"K Thomson","year":"2013","unstructured":"Thomson K, Luis DJ, Lagu J, et al. Investigation of Hepatitis E Outbreak among Refugees \u2014 Upper Nile, South Sudan, 2012\u20132013. Morb Mortal Wkly Rep. 2013;62(29):581\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"key":"15792_CR32","unstructured":"Norwegian Institute of Public Health. An Effectiveness Trial (Phase IV) to Evaluate Protection of Pregnant Women by Hepatitis E Virus (HEV) Vaccine in Bangladesh and Risk Factors for Severe HEV Infection. clinicaltrials.gov. ; 2020. Accessed February 21, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02759991."},{"key":"15792_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2018.07.002","author":"SY Liang","year":"2018","unstructured":"Liang SY, Messenger N. Infectious Diseases after Hydrologic Disasters. Emerg Med Clin North Am. 2018. https:\/\/doi.org\/10.1016\/j.emc.2018.07.002.","journal-title":"Emerg Med Clin North Am"},{"key":"15792_CR34","unstructured":"Optimizing HIV testing algorithms toolkit. Accessed March 9., 2022. https:\/\/www.who.int\/tools\/optimizing-hiv-testing-algorithms-toolkit."},{"key":"15792_CR35","doi-asserted-by":"publisher","unstructured":"Mobula LM, Samaha H, Yao M, Gueye AS, Diallo B, Umutoni C, Anoko J, Lokonga JP, Minikulu L, Mossoko M, Bruni E, Carter S, Jombart T, Fall IS, Ahuka-Mundeke S. Recommendations for the COVID-19 response at the National Level based on Lessons learned from the Ebola Virus Disease Outbreak in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2020 Jul;103(1):12\u20137. https:\/\/doi.org\/10.4269\/ajtmh.20-0256. Epub 2020 May 19. PMID: 32431285; PMCID: PMC7356463.","DOI":"10.4269\/ajtmh.20-0256"},{"key":"15792_CR36","doi-asserted-by":"publisher","unstructured":"Katz R. Use of revised International Health Regulations during influenza A (H1N1) epidemic, 2009. Emerg Infect Dis. 2009 Aug;15(8):1165\u201370. https:\/\/doi.org\/10.3201\/eid1508.090665. PMID: 19751576; PMCID: PMC2815989.","DOI":"10.3201\/eid1508.090665"},{"key":"15792_CR37","doi-asserted-by":"publisher","unstructured":"Polonsky JA, Baidjoe A, Kamvar ZN, Cori A, Durski K, Edmunds WJ, Eggo RM, Funk S, Kaiser L, Keating P, de Waroux OLP, Marks M, Moraga P, Morgan O, Nouvellet P, Ratnayake R, Roberts CH, Whitworth J, Jombart T. Outbreak analytics: a developing data science for informing the response to emerging pathogens. Philos Trans R Soc Lond B Biol Sci. 2019 Jul 8;374(1776):20180276. https:\/\/doi.org\/10.1098\/rstb.2018.0276. PMID: 31104603; PMCID: PMC6558557.","DOI":"10.1098\/rstb.2018.0276"},{"key":"15792_CR38","doi-asserted-by":"publisher","unstructured":"Webb GW, Dalton HR. Hepatitis E: an underestimated emerging threat. Ther Adv Infect Dis. 2019 Apr 3;6:2049936119837162. https:\/\/doi.org\/10.1177\/2049936119837162. PMID: 30984394; PMCID: PMC6448100.","DOI":"10.1177\/2049936119837162"},{"key":"15792_CR39","doi-asserted-by":"publisher","unstructured":"Shata MT, Daef EA, Zaki ME, Abdelwahab SF, Marzuuk NM, Sobhy M, Rafaat M, Abdelbaki L, Nafeh MA, Hashem M, El-Kamary SS, Shardell MD, Mikhail NN, Strickland GT, Sherman KE. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Trans R Soc Trop Med Hyg. 2012 Oct;106(10):613\u20138. https:\/\/doi.org\/10.1016\/j.trstmh.2012.07.004. Epub 2012 Aug 28. PMID: 22938992.","DOI":"10.1016\/j.trstmh.2012.07.004"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-15792-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T09:03:08Z","timestamp":1686560588000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-15792-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["15792"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-15792-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1120"}}